Cardiovascular Systems (CSII) Stock Forecast, Price & News

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardiovascular Systems in the last twelve months. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "reduce" CSII shares.
View CSII analyst ratings or view top-rated stocks.

2 Wall Street analysts have issued 1-year price targets for Cardiovascular Systems' shares. Their CSII share price forecasts range from $15.00 to $25.00. On average, they anticipate the company's stock price to reach $20.00 in the next twelve months.
View analysts price targets for CSII or view top-rated stocks among Wall Street analysts.

Cardiovascular Systems, Inc. (NASDAQ:CSII) issued its quarterly earnings data on Wednesday, February, 8th. The medical device company reported ($0.20) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.15) by $0.05. The medical device company had revenue of $61.45 million for the quarter, compared to analysts' expectations of $63.06 million. Cardiovascular Systems had a negative trailing twelve-month return on equity of 15.39% and a negative net margin of 15.79%. Cardiovascular Systems's quarterly revenue was up 3.9% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.23) earnings per share.

35 employees have rated Cardiovascular Systems Chief Executive Officer Scott Ward on Glassdoor.com. Scott Ward has an approval rating of 81% among the company's employees. 83.0% of employees surveyed would recommend working at Cardiovascular Systems to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardiovascular Systems investors own include Gilead Sciences (GILD), AbbVie (ABBV), Advanced Micro Devices (AMD), Medtronic (MDT), Pfizer (PFE), ACADIA Pharmaceuticals (ACAD), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK) and Procter & Gamble (PG).

Cardiovascular Systems trades on the NASDAQ under the ticker symbol "CSII."

Cardiovascular Systems' stock is owned by many different retail and institutional investors. Top institutional investors include Walleye Trading LLC (0.00%), BROOKFIELD Corp ON (0.00%), Simplex Trading LLC (0.00%) and Picton Mahoney Asset Management (0.00%). Insiders that own company stock include Erik Paulsen, Jeffrey S Points, Martha Goldberg Aronson, Rhonda J Robb and Scott R Ward.
View institutional ownership trends.

One share of CSII stock can currently be purchased for approximately $20.00.

Cardiovascular Systems (NASDAQ:CSII) has a market capitalization of $843.96 million and generates $239.84 million in revenue each year. The medical device company earns $-36,930,000.00 in net income (profit) each year or ($0.97) on an earnings per share basis.

The company employs 780 workers across the globe.

Cardiovascular Systems' mailing address is 1225 OLD HWY 8 NW, ST. PAUL MN, 55112. The official website for the company is www.csi360.com. The medical device company can be reached via phone at (651) 259-1600, via email at j.nielsen@csi360.com, or via fax at 612-677-3355.